01.30.26 -- Trump's Big Pharma Deals Drive CDMO Investments

Join Outsourced Pharma Chief Editor Jeff Buguliskis and our panel of industry experts as they share practical advice, reveal what to look for beyond the surface, and answer your toughest questions about selecting a CDMO partner that can truly deliver. Register for free today!

Redesigning chemical processes with green chemistry principles can cut emissions, reduce waste, and improve efficiency. See how smarter synthesis and digital tools enable sustainable API manufacturing.

With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence

Successful ADC lyophilization requires a robust, individualized process driven by thermal characterization using DSC and FDM to define the critical parameters for efficient manufacturing.

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

Explore how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.

Finding alternative solvent approaches could allow for lower volumes of less toxic solvents, significantly improving both the environmental and human health implications of new drugs produced.

When facing a malfunction, having an effective disaster recovery plan can make the difference between a swift fix, and losing your samples and time.

Explore how infrastructure, equipment strategy, and advanced technologies shape a more reliable path for scaling sterile injectable programs.

See how a cutting-edge, multi-purpose isolator line delivers high-speed, precision fill/finish. This flexible technology supports a diverse range injectable therapies.

Our team of experts can support you in all aspects of scale-up and technology transfer through our state-of-the-art development and manufacturing facility.

Delve into the full range of services, including product development, analytical method development, project management, and custom chemical synthesis.